POLYTHÉRAPIE À BASE DÝANTICORPS CONTRE L'AGONISTE TLR9 ET CSF-1R HUMAIN
- 专利权人:
- F. Hoffmann-La Roche AG
- 发明人:
- 申请号：
- EP14718115.0
- 公开号：
- EP2989125B1
- 申请日:
- 2014.04.17
- 申请国别(地区):
- EP
- 年份:
- 2019
- 代理人:
- 摘要：
- The present invention relates to the combination therapy of antibodies against human CSF-1R with a TLR9 agonist.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Combination Therapy of Antibodies against human csf-1r with a TLR9 agonist
- COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND TLR9 AGONIST
- COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND TLR9 AGONIST
- COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND TLR9 AGONIST
- COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND TLR9 AGONIST
